| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 9 |
| 1 | RIVAROXABAN | 9 |
| 2 | ASPIRIN | 8 |
| 3 | DOCETAXEL | 8 |
| 4 | DOCETAXEL ANHYDROUS | 8 |
| 5 | FLUOROURACIL | 8 |
| 6 | FLUOROURACIL CREAM, 0.5% | 8 |
| 7 | OXALIPLATIN | 8 |
| 8 | TRASTUZUMAB | 8 |
| 9 | ASPIRIN 325 MG | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | A AND D OINTMENT | 1 | 0.1667 |
| 1 | BRILLIANT BLUE G | 1 | 0.0476 |
| 2 | ANACARDIUM ORIENTALE, AQUA MARINA, ARGENTUM NITRICUM, ASARUM CANADENSE, BLATTA ORIENTALIS, BUFO RANA, CEREBRUM SUIS, CLEMATIS ERECTA, CUPRUM ACETICUM, HYPOTHALAMUS SUIS, IGNATIA AMARA, KALI PHOSPHORICUM, LACHESIS MUTUS, MERCURIUS SOLUBILIS, NATRUM SULPHURICUM, PLACENTA TOTALIS SUIS, RHUS TOX, THUJA OCCIDENTALIS, THYMOLUM, VALERIANA OFFICINALIS | 1 | 0.0476 |
| 3 | FLUPHENAZINE DECANOATE | 1 | 0.0023 |
| 4 | OXYMETAZOLINE HCL | 1 | 0.0018 |
| 5 | CEFTAROLINE FOSAMIL | 1 | 0.0012 |
| 6 | ACYCLOVIR SODIUM | 1 | 0.0008 |
| 7 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 1 | 0.0004 |
| 8 | HYDRALAZINE HYDROCHLORIDE | 1 | 0.0004 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 3 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 1 | Factor Xa Inhibitor [EPC] | 11 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 11 |
| 3 | Benzodiazepine [EPC] | 10 |
| 4 | Microtubule Inhibitor [EPC] | 9 |
| 5 | Corticosteroid [EPC] | 8 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 8 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 8 |
| 8 | Platinum-based Drug [EPC] | 8 |
| 9 | Insulin Analog [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Disclosing Agent [EPC] | 1 | 0.0476 |
| 1 | Calcitonin [EPC] | 1 | 0.0003 |
| 2 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |
| 3 | Gadolinium-based Contrast Agent [EPC] | 1 | 0.0002 |
| 4 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |
| 5 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 6 | Cannabinoid [EPC] | 1 | 0.0001 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 8 | 0.0001 |
| 8 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 9 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |